Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)

Name: Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)
Published: 2020
License: Public Domain

Octapharma · 2020

ClinicalTrials.gov · Datasets · License: Public Domain · 2020

Open Source ↗

chronic lymphocytic leukemia, hypogammaglobulinemia, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)

Related documents